Celularity
CELU
72 hedge funds and large institutions have $81.1M invested in Celularity in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 10 reducing their positions, and 10 closing their positions.
1,452% more call options, than puts
Call options by funds: $2.87M | Put options by funds: $185K
230% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 10
60% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 10
9% more funds holding
Funds holding: 66 → 72 (+6)
0.29% more ownership
Funds ownership: 2.17% → 2.46% (+0.29%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
23% less capital invested
Capital invested by funds: $105M → $81.1M (-$24.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.15M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.56M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.89M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.37M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$6.35M |
| 2 |
PT
Palantir Technologies
Aventura,
Florida
|
-$2.22M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$532K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$247K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$116K |
CELU Hedge Fund Activity: Q3 2022 in Review
72 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q3 2022, worth a combined $81.1M — down 23% from $105M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new CELU positions and 10 closed out — a net gain of 6 holders — while 33 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, adding an estimated $8.15M. The largest seller was Armistice Capital, exiting entirely with an estimated $6.35M sold.
- 72 institutional investors held Celularity (CELU) as of Q3 2022, up from 66 in Q2 2022.
- Funds reported $81.1M of Celularity stock for Q3 2022, down 23% quarter-over-quarter.
- 16 funds opened new Celularity positions in Q3 2022 and 10 closed out, a net change of +6 holders.
- The largest Celularity buyer in Q3 2022 was BlackRock, an estimated $8.15M added.
- The largest Celularity seller in Q3 2022 was Armistice Capital, an estimated $6.35M sold.
Based on aggregated 13F filings for Q3 2022.